Summit Investment Advisors »

Immix Biopharma shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $38k 3.7k 10.31

More positions owned by Summit Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Ishares Tr Etf (IVV)
Alphabet Inc Class A cs (GOOGL)
Vanguard Europe Pacific ETF (VEA)
Tesla Motors (TSLA)
Vanguard Index Fds Etf (VOO)
Ishares Tr Etf (AGG)
Spdr Series Trust Etf (ONEV)

View all positions for Summit Investment Advisors

Top funds holding Immix Biopharma

Jupiter Topco
Henderson Group
Saturn V Capital Management
Eventide Asset Management
BlackRock
Deep Track Capital
Vanguard Capital Management
Opaleye Management
Millennium Management
UBS Group
Marshall Wace
Wellington Management Company
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Velan Capital Investment Management

View all funds holding Immix Biopharma